跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要核心是通用贝叶斯稀疏回归的计算加速,药物风险比较不足以确认其属于因果推断方法。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Akihiko Nishimura
Marc A. Suchard

以先验预条件共轭梯度法加速大样本高维贝叶斯稀疏回归的 Gibbs 抽样

研究问题
大样本、高维贝叶斯稀疏回归反复抽取高维高斯变量时,如何避免昂贵的精度矩阵构造与分解,降低后验计算成本?
方法与思路
作者通过随机右端项将高斯抽样转为线性系统求解,以共轭梯度的矩阵向量乘法计算,并建立先验预条件的快速收敛理论。
材料陈述的贡献
摘要称,在比较两种抗凝药不良事件风险的观察研究中,该算法带来数量级加速,使计算时间从两周缩短至不足一天。
阅读关注点
应核对预条件器构造、迭代停止误差对抽样分布的影响、收敛保证条件,以及应用计时比较的硬件与算法配置。
阅读边界
仅据版本未注明的 Europe PMC/PubMed 索引摘要;加速幅度来自特定应用,计算改进不提供因果识别保证,也不能推断刊本变化。

原文摘要

In a modern observational study based on healthcare databases, the number of observations and of predictors typically range in the order of 10^{5}-10^{6} and of 10^{4}-10^{5}. Despite the large sample size, data rarely provide sufficient information to reliably estimate such a large number of parameters. Sparse regression techniques provide potential solutions, one notable approach being the Bayesian method based on shrinkage priors. In the "large n and large p" setting, however, the required posterior computation encounters a bottleneck at repeated sampling from a high-dimensional Gaussian distribution, whose precision matrix Φ is expensive to compute and factorize. In this article, we present a novel algorithm to speed up this bottleneck based on the following observation: We can cheaply generate a random vector b such that the solution to the linear system Φβ = b has the desired Gaussian distribution. We can then solve the linear system by the conjugate gradient (CG) algorithm through matrix-vector multiplications by Φ; this involves no explicit factorization or calculation of Φ itself. Rapid convergence of CG in this context is guaranteed by the theory of prior-preconditioning we develop. We apply our algorithm to a clinically relevant large-scale observational study with n = 72,489 patients and p = 22,175 clinical covariates, designed to assess the relative risk of adverse events from two alternative blood anti-coagulants. Our algorithm demonstrates an order of magnitude speed-up in posterior inference, in our case cutting the computation time from two weeks to less than a day. Supplementary materials for this article are available online.

笔记与分组